POLE and carcinosarcoma: POLE mutations are more frequent in high-grade ECs (12.1%) than in low-grade ECs (6.2%) and occur in 12.4% of undifferentiated/dedifferentiated, 3.8% of clear, and 5.3% of carcinosarcomas.